ADENOVIRUS 2 CODED EARLY GLYCOPROTEIN
ADENOVIRUS 2 CODED EARLY GLYCOPROTEIN
批准号:
2087292
负责人:
WILLIAM SM WOLD
金额:
$19.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-05-01 至 1995-09-29
关键词:
Adenoviridae DNA replication Escherichia coli X ray crystallography affinity chromatography antiserum binding proteins biological signal transduction cell membrane chimeric proteins cytotoxic T lymphocyte epidermal growth factor gel electrophoresis gene expression genetic mapping genetic transcription genetic translation glycoproteins growth factor receptors hamsters human tissue immunoelectron microscopy immunofluorescence technique immunoregulation laboratory rabbit major histocompatibility complex membrane proteins nucleic acid sequence oncogenic virus posttranslational modifications protein biosynthesis protein engineering protein sequence protein signal sequence protein structure radionuclides radiotracer site directed mutagenesis sulfur transfection tumor necrosis factor alpha virus DNA virus cytopathogenic effect virus genetics virus protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Proteins generally are localized at specific sites within the cell, and
therefore regulatory information must exist in the structure of the protein
to assure that they arrive at the correct destination. Our major objective
is to identify this information, using as a model the 19 kDa plasma
membrane glycoprotein (gp19K) coded by early region E3 adenovirus 1 (Ad2)
or Ad5, and using a genetic approach. Gp19K is an abundant protein whose
structure is known, and viable virus mutants can easily be constructed by
in vitro site directed mutagenesis. Antisera are available against
purified gp19K as well as synthetic peptides corresponding to gp19K.
Gp19K has a 17 amino acid N-terminal "signal" sequence, two high-mannose
oligosaccharides, and a 20 amino acid hydrophobic transmembrane domain
followed by a 15 amino acid polar domain at the C-terminus. We have
isolated virus mutants with sequenced lesions in the signal sequence, the
glycosylation sites, and the C-terminal hydrophobic and/or polar domains.
We propose to characterize these mutants in terms of processing and
transport. Data are now available with some mutants. In a collaborative
study, the mutants will be studied as a unique model for viral antigenclass
1 MHC antigen interaction. Other plasmid mutants, some sequenced, are
available to construct additional virus mutants. We propose two novel and
simple methods that apply standard techniques in bacterial genetics to
isolate random missense mutations in gp19K.
Region E3 encodes several other membrane proteins whose structures are
fundamentally different from gp19K. We propose genetic studies, similar to
those with gp19K, to identify the membrane-association and transport
signals for these proteins. Virus mutants in some of the these genes,
including fusions to gp19K, are currently available and additional mutants
are easily constructed. Peptide antisera targeted to each of these
proteins are available, and potent antisera directed fusion proteins
synthesized by expression vectors will be generated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Syrian Hamster as a Permissive Model for Testing Anti-Adenovirus Drugs
-
批准号:7327485
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2007
-
负责人:WILLIAM SM WOLD
-
依托单位:
Hamster Model for Oncolytic Adenovirus Vectors
-
批准号:7804580
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2006
-
负责人:WILLIAM SM WOLD
-
依托单位:
Hamster Model for Oncolytic Adenovirus Vectors
-
批准号:7417506
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2006
-
负责人:WILLIAM SM WOLD
-
依托单位:
Hamster Model for Oncolytic Adenovirus Vectors
-
批准号:7247952
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2006
-
负责人:WILLIAM SM WOLD
-
依托单位:
Hamster Model for Oncolytic Adenovirus Vectors
-
批准号:7613467
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2006
-
负责人:WILLIAM SM WOLD
-
依托单位:
Hamster Model for Oncolytic Adenovirus Vectors
-
批准号:7149637
-
项目类别:
-
资助金额:$26.09万
-
财政年份:2006
-
负责人:WILLIAM SM WOLD
-
依托单位:
Animal Model for Adenovirus Oncolytic Vectors
-
批准号:6792925
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2004
-
负责人:WILLIAM SM WOLD
-
依托单位:
Molecular Basis of Flavivirus Neurovirulence
-
批准号:6946853
-
项目类别:
-
资助金额:$43.51万
-
财政年份:2003
-
负责人:WILLIAM SM WOLD
-
依托单位:
Molecular Basis of Flavivirus Neurovirulence
-
批准号:7119687
-
项目类别:
-
资助金额:$44.17万
-
财政年份:2003
-
负责人:WILLIAM SM WOLD
-
依托单位:
Molecular Basis of Flavivirus Neurovirulence
-
批准号:7284400
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2003
-
负责人:WILLIAM SM WOLD
-
依托单位:
Molecular Basis of Flavivirus Neurovirulence
-
批准号:6803173
-
项目类别:
-
资助金额:$42.68万
-
财政年份:2003
-
负责人:WILLIAM SM WOLD
-
依托单位:
Adenovirus Replication-Competent Anti-Cancer Vector
-
批准号:6608170
-
项目类别:
-
资助金额:$35.98万
-
财政年份:1999
-
负责人:WILLIAM SM WOLD
-
依托单位:
ADENOVIRUS REPLICATION COMPETENT ANTICANCER VECTOR
-
批准号:2867999
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:WILLIAM SM WOLD
-
依托单位:
Adenovirus Replication-Competent Anti-Cancer Vector
-
批准号:6552215
-
项目类别:
-
资助金额:$35.13万
-
财政年份:1999
-
负责人:WILLIAM SM WOLD
-
依托单位:
YELLOW FEVER 17D-BASED CHIMERIC FLAVIVIRUS VACCINES
-
批准号:6510870
-
项目类别:
-
资助金额:$30.63万
-
财政年份:1998
-
负责人:WILLIAM SM WOLD
-
依托单位:
ADENOVIRUS DEATH PROTEIN
-
批准号:2712812
-
项目类别:
-
资助金额:$28.72万
-
财政年份:1996
-
负责人:WILLIAM SM WOLD
-
依托单位:
ADENOVIRUS DEATH PROTEIN
-
批准号:2895629
-
项目类别:
-
资助金额:$29.67万
-
财政年份:1996
-
负责人:WILLIAM SM WOLD
-
依托单位:
ADENOVIRUS DEATH PROTEIN
-
批准号:6173289
-
项目类别:
-
资助金额:$30.65万
-
财政年份:1996
-
负责人:WILLIAM SM WOLD
-
依托单位:
ADENOVIRUS DEATH PROTEIN
-
批准号:2115262
-
项目类别:
-
资助金额:$26.95万
-
财政年份:1996
-
负责人:WILLIAM SM WOLD
-
依托单位:
ADENOVIRUS DEATH PROTEIN
-
批准号:2429927
-
项目类别:
-
资助金额:$27.82万
-
财政年份:1996
-
负责人:WILLIAM SM WOLD
-
依托单位:
海外基金